Thermo Fisher Scientific Forms Technology Alliance Partnership with Barnett Institute, Northeastern University - - Chromatography Online
Thermo Fisher Scientific Forms Technology Alliance Partnership with Barnett Institute, Northeastern University

LCGC Europe eNews

Thermo Fisher Scientific (California, USA) has entered into a Technology Alliance Partnership agreement with the Barnett Institute, Northeastern University (Massachusetts, USA). The partnership will advance research into mass liquid chromatography-mass spectrometry (LC–MS) applications.

The collaboration will include the sharing of samples, data and research that could result in improvements of instruments and software. Three main research areas will be focused on: comprehensive characterization of complex proteins; ultra-trace analysis methodologies of proteomic samples; and new LC–MS-based methods for the analysis of biosimilars.

“Academic research labs are tremendous sources of innovation, which is why we’re so pleased to collaborate with Northeastern scientists who have particular expertise in combining the strengths of separation science and high resolution MS analysis of proteins,” said Iain Mylchreest, VP, Research and Development, Thermo Fisher.  

“This agreement formalizes our commitment to actively expedite the development and application of important new technologies,” said Professor Barry Karger, the Barnett Institute’s Director.  “We are very pleased to strengthen the ongoing collaboration of our laboratory with Thermo Fisher in LC–MS protein analysis for biomedical and biotechnology applications.”

For more information please visit:


blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:



Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration

Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: HPLC for Characterization and Quality Control of Therapeutic Monoclonal Antibodies

MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis

LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Can I Inject? Part I: Injecting in Mobile Phase

More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>

Source: LCGC Europe eNews,
Click here